UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies

🤖AI Özeti

AstraZeneca and GSK, two of the largest pharmaceutical companies in the U.K., reported first-quarter profits that surpassed market expectations. This unexpected financial performance comes despite ongoing challenges posed by U.S. healthcare policies. The results indicate resilience within the sector, as these companies navigate regulatory hurdles while still achieving growth. Investors may view this as a positive sign for the pharmaceutical industry in the face of external pressures.